Pancreatic Intraepithelial Neoplasia-1A
|
disease |
|
Neoplastic Process
|
6
|
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Skin Papilloma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
8
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Familial Partial Lipodystrophy, Type 2
|
disease |
Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
16
|
23
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Myeloblastic leukemia
|
disease |
|
Neoplastic Process
|
22
|
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
B Lymphoblastic Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
25
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Persistent Hyperplastic Primary Vitreous
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases
|
Congenital Abnormality
|
33
|
4
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Smoldering myeloma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
41
|
1
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Malignant lymphoma - lymphoplasmacytic
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
53
|
10
|
0.010 |
None |
1.000 |
1 |
|
1995 |
1995 |
Salivary duct carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
54
|
9
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Dysplastic Nevus
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms
|
Neoplastic Process
|
104
|
7
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Acute myelomonocytic leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
105
|
3
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Angioimmunoblastic Lymphadenopathy
|
disease |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
109
|
8
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Childhood T Acute Lymphoblastic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
119
|
2
|
0.010 |
None |
< 0.001 |
1 |
|
2017 |
2017 |
Acoustic Neuroma
|
disease |
Neoplasms; Nervous System Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
131
|
3
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Hemoglobin measurement
|
phenotype |
|
Laboratory Procedure
|
131
|
224
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
Monocyte count procedure
|
phenotype |
|
Laboratory Procedure
|
139
|
296
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Monocyte count result
|
phenotype |
|
Laboratory or Test Result
|
139
|
296
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Endometrial Hyperplasia
|
disease |
Female Urogenital Diseases and Pregnancy Complications
|
Disease or Syndrome
|
143
|
6
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Lean body mass
|
phenotype |
|
Clinical Attribute
|
144
|
211
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Myotonic Dystrophy
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
155
|
4
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Waldenstrom Macroglobulinemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Neoplastic Process
|
162
|
15
|
0.010 |
None |
1.000 |
1 |
|
1995 |
1995 |
Alcohol consumption
|
phenotype |
Behavior and Behavior Mechanisms
|
Individual Behavior
|
210
|
535
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Paresis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
216
|
49
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Mammary Neoplasms, Experimental
|
phenotype |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
218
|
|
0.200 |
None |
1.000 |
1 |
|
2006 |
2006 |
Monoclonal Gammopathy of Undetermined Significance
|
disease |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
227
|
20
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |